These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25444906)

  • 1. Adeno-associated virus-mediated cancer gene therapy: current status.
    Luo J; Luo Y; Sun J; Zhou Y; Zhang Y; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt B):347-56. PubMed ID: 25444906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer gene therapy using adeno-associated virus vectors.
    Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
    Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vectrology of adeno-associated viruses (AAV).
    Skubis-Zegadło J; Stachurska A; Małecki M
    Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders.
    Mak KY; Rajapaksha IG; Angus PW; Herath CB
    Curr Gene Ther; 2017; 17(1):4-16. PubMed ID: 28292253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus vectors: potential applications for cancer gene therapy.
    Li C; Bowles DE; van Dyke T; Samulski RJ
    Cancer Gene Ther; 2005 Dec; 12(12):913-25. PubMed ID: 15962012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
    Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthopaedic gene therapy using recombinant adeno-associated virus vectors.
    Ke J; Zheng LW; Cheung LK
    Arch Oral Biol; 2011 Jul; 56(7):619-28. PubMed ID: 21354554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy using adeno-associated virus vectors.
    Daya S; Berns KI
    Clin Microbiol Rev; 2008 Oct; 21(4):583-93. PubMed ID: 18854481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vector-mediated gene therapies.
    Hollinger K; Chamberlain JS
    Curr Opin Neurol; 2015 Oct; 28(5):522-7. PubMed ID: 26263476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy using AAV (adeno-associated virus) vectors].
    Ozawa K
    Uirusu; 2003 Dec; 53(2):163-70. PubMed ID: 15080081
    [No Abstract]   [Full Text] [Related]  

  • 13. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.
    Bera A; Sen D
    Heart Fail Rev; 2017 Nov; 22(6):795-823. PubMed ID: 28589503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus vectorology, manufacturing, and clinical applications.
    Grieger JC; Samulski RJ
    Methods Enzymol; 2012; 507():229-54. PubMed ID: 22365777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development in the studies of AAV-mediated gene therapy in retina].
    Zou X; Sui RF; Dong FT
    Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):1049-52. PubMed ID: 22336072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth.
    Watanabe M; Nasu Y; Kashiwakura Y; Kusumi N; Tamayose K; Nagai A; Sasano T; Shimada T; Daida H; Kumon H
    Hum Gene Ther; 2005 Jun; 16(6):699-710. PubMed ID: 15960601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
    Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
    World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
    McCarty DM; Young SM; Samulski RJ
    Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.